ABALGIN RETARD

Main information

  • Trade name:
  • ABALGIN RETARD 150 mg prolonged-release capsule, hard
  • Dosage:
  • 150 mg
  • Pharmaceutical form:
  • prolonged-release capsule, hard
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ABALGIN RETARD 150 mg prolonged-release capsule, hard
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Dextropropoxyphene

Status

  • Source:
  • Fimea
  • Authorization status:
  • MA withdrawn after authorization
  • Authorization number:
  • 5297
  • Authorization date:
  • 05-02-2010
  • Last update:
  • 26-07-2018